Selank for anxiety: promising Russian research or overhyped peptide?

What did @nursey_mercy actually say?

The creator, presenting as a nurse, promotes a nasal spray peptide she calls "C-Long" as an anxiety solution, specifically targeted at women who "run a little anxious." She claims it works "immediately," takes the edge off without sedation, keeps you thinking clearly, and even boosts creativity. She ends with a phone number to call, which is a direct solicitation.

A few things to flag right away. The product is referred to as "C-Long," not Selank, which is what the caption names. These may or may not be the same formulation. She is describing what sounds like an acute, on-demand anxiolytic effect from a single nasal dose. That is a specific pharmacological claim, and it deserves scrutiny. She also frames this as a personal endorsement tied to a call-to-action, which sits in uncomfortable territory between testimony and advertisement.

Does the science back this up?

Selank has real research behind it, but almost none of it supports the "one spray and feel it immediately" framing she uses. The evidence is more modest and longer-term than she implies.

Selank is a synthetic heptapeptide analog of tuftsin, developed by the Russian Institute of Molecular Genetics. It has been studied primarily in Russian literature, which limits independent replication. Seredenin and Voronina (2009, Eksperimental'naya i Klinicheskaya Farmakologiya) documented anxiolytic effects in animal models and some human trials. A clinical study by Zozulya et al. (2001, Bulletin of Experimental Biology and Medicine) found reduced anxiety scores in patients with generalized anxiety disorder after repeated intranasal dosing over days, not after a single spray.

The mechanism most cited involves modulation of GABA-A receptors and enkephalin metabolism, similar in some ways to benzodiazepines but without the same receptor binding profile. That is genuinely interesting. But "goes to work immediately" after one dose is not what the published trials show. The bioavailability via intranasal route is supported, but acute single-dose human data on mood is thin.

What did they get wrong (or right)?

She gets partial credit on the mechanism. Selank does appear to modulate anxiety pathways without the heavy sedation associated with benzodiazepines. The claim that it "doesn't completely put me out" and that "you're still thinking clear" is at least directionally consistent with animal and limited human data showing less cognitive impairment than classical anxiolytics. Grigoriev et al. (2016, CNS Drug Reviews) noted the absence of amnestic effects as a distinguishing feature.

What she gets wrong, fairly significantly, is the immediacy claim. Saying it "goes to work immediately" and framing it as something you reach for on a stressful day implies acute, fast-acting relief from a single dose. The clinical data does not support that framing. She also conflates improved anxiety with enhanced creativity, citing "vision narrows" under stress. That part is based on real stress psychology, but using it to imply the peptide specifically unlocks creative cognition is a stretch with no direct Selank evidence behind it.

• The "C-Long" branding is unverified and not a recognized pharmaceutical name for Selank.
• Calling a phone number to purchase a peptide nasal spray is not the same as accessing regulated care.
• The blanket targeting of "ladies that run a little anxious" is not a clinical indication.

What should you actually know?

Selank is not FDA-approved. It is not a regulated drug in the United States. If you are buying it through a phone number from a TikTok video, you have no guarantee of purity, concentration, or sterility. Compounded peptides vary significantly across suppliers, and intranasal delivery of contaminated or incorrectly dosed peptides carries real risk.

If you have anxiety worth treating, that is a clinical conversation, not a spray-and-go fix. Anxiety disorders respond to evidence-based treatments including cognitive behavioral therapy and FDA-approved medications with decades of safety data. Selank is an area of ongoing research, not a proven first-line treatment.

The peptide space is full of plausible mechanisms and thin human trial data. Selank is one of the more studied entries in that category, but "more studied" in this field still means the bar is low. Anyone presenting this as a reliable, immediate anxiety fix is outpacing what the evidence actually shows.